Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Middle-South Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of xanthine-based Active Pharmaceutical Ingredients (APIs) and finished drug products. The company is globally recognized as one of the largest producers of caffeine anhydrous, theophylline, and aminophylline, catering to both the pharmaceutical and food/beverage industries. Operating as a key subsidiary of Hunan Erkang Pharmaceutical, it maintains large-scale GMP-certified manufacturing facilities in Hunan province. Its product portfolio is primarily focused on small molecule therapeutics for respiratory conditions and central nervous system stimulation. The company serves a diverse international clientele, exporting bulk ingredients to numerous countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Middle-South Pharmaceutical.